Purpose
To identify new drugs for treating common human parasitic diseases caused by nematode worms that target their essential bacterial symbiont, Wolbachia, by developing a screening strategy based on the model nematode Caenorhabditis elegans.
Grantee
Division
Global Health
Date
APRIL 2013
Region served
GLOBAL
Committed amount
$100,000
Grant topic
Discovery and Translational Sciences
Duration (months)
19
Grantee location
Liverpool, United Kingdom
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.